Delivery Order SPE2DB22D3501-SPE2DB25FTV38

Award Date 12/16/24
Potential Completion Date 12/17/24
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTV38
    Delivery Order

This federal contract award, valued at $9,491.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the place of performance is Conshohocken, PA. This award demonstrates Amerisourcebergen's extensive capabilities in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to federal agencies such as the DLA, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/17/25, 10:04 AM